Breast density challenges
Dense tissue can make small cancers harder to see on mammograms. Up to 50–74% of women under 50 have dense breasts.
Information for Patients
Overview
LiquidMammo™ is a non-invasive blood test designed to complement mammography by analyzing cancer‑associated microRNA patterns. It is particularly helpful for patients with dense breast tissue, where standard imaging may be less sensitive.
LiquidMammo is being developed as a CLIA Laboratory Developed Test (LDT). It is not yet FDA‑cleared or FDA‑approved.
Why patients consider a supplemental test
Non‑invasive
A simple blood draw — no radiation, no compression, no imaging discomfort.
Added confidence
LiquidMammo provides molecular information that complements imaging and clarifies uncertain results.
How the test works
1 — Clinician orders the test
LiquidMammo is ordered through your healthcare provider—just like a routine blood test.
2 — Blood sample collected
A standard blood draw is performed in the clinic or at a partner laboratory.
3 — microRNA signature analyzed
The laboratory analyzes a multi‑marker microRNA panel known to show early changes associated with cancer biology.
4 — Results sent to clinician
Your provider receives a structured report with result classification and screening recommendations.
Who may benefit
- Women with dense breasts (BI‑RADS C or D).
- Patients with a family history or elevated risk.
- Patients who postpone mammography due to discomfort.
- Women under 50, where density is more common.
- Patients needing more frequent monitoring between imaging visits.
Frequently asked
Is this a replacement for mammography?
No. LiquidMammo supplements imaging — it does not replace it.
Will insurance cover it?
Insurance coverage for LDTs varies. Your clinician can advise as validation progresses.
How soon will results be available?
Timing depends on the clinic's workflow. Your provider will advise.
Patient early‑access
LiquidMammo works with select clinics during the validation phase. If you would like your provider to participate, they can contact our team.